Provia Labs Expands Distribution of its Unique Proviasette™ Frozen Biospecimen Container - Enters ex
Enters Expanding Market in the United Kingdom and Ireland for Tissue Banking.
Provia Laboratories, LLC announced today the expansion of distribution for its unique Proviasette™ frozen biospecimen container. Under an agreement with ProScan Middle East FZE, the Proviasette™ will be marketed to hospitals, laboratories, research universities, tissue banking companies and pharmaceutical companies throughout the Gulf Region and elsewhere in the Middle East.
Provia Labs introduced the Proviasette™, the next-generation biospecimen storage container, in 2011. The Proviasette™ improves upon a design used by leading academic and commercial laboratories around the world to efficiently store hundreds of thousands of snap frozen and OCT-embedded biospecimens in -80 OC or vapor-phase liquid nitrogen (LN2) freezers.
In hundreds of labs worldwide, tissue samples sometimes valued in the thousands of dollars are stored in glass, foil or other makeshift containers. These containers are subject to failure at low temperature, are difficult to label and track, and take up far too much freezer space.
Well-designed and GMP-manufactured, the dual polymer construction of the Proviasette™ prevents the cap and base from seizing at low temperatures. It is virtually indestructible in a lab setting, and is certified 95kPa compliant. Highly space efficient, the Proviasette™ enables up to 8,400 samples to fit conveniently into a standard -80 OC freezer.
Proviasette™ is the optimal way to maintain the integrity and tracking of stored biospecimens, especially high-value cryo-preserved biospecimens used in clinical research.
The Middle East is home to a growing number of research laboratories and tissue banking facilities that will be excited to take advantage of the unique features and benefits of the Proviasette™ line of products," explained Mr. Ralph D. Childs, Managing Partner at ProScan Middle East FZE. Mr. Childs is based in Dubai, United Arab Emirates.
"Mr. Childs has an extensive knowledge of the healthcare industry in the Middle East, developed over years of working there with hospitals, laboratories and research companies," said Mr. Howard Greenman, CEO of Provia Laboratories, LLC.
"We are extremely excited to have ProScan Middle East FZE representing us in the region. An innovative product and a highly-connected, seasoned expert in the local market make a potent combination, and we expect to see significant growth in Proviasette™ adoption there."
For further information about Proviasette™, please call Provia Labs at +1 (781) 652-4815, email email@example.com, or visit www.proviasettes.com.
About Provia Laboratories LLC Headquartered in Lexington, MA, Provia Laboratories, LLC (www.provialabs.com) is a healthcare services company specializing in high-quality biobanking (preservation of biological specimens). Provia Labs offers the Proviasette™ product range for use in complex biobanking environments to improve sample logistics, security and quality. The company's Store-A-Tooth™ service platform enables the collection, transport, processing and storage of dental stem cells for potential use in future stem-cell therapies. Provia advises industrial, academic and governmental clients on matters related to the preservation of biological specimens for research and clinical use. Provia Labs is a member of ISBER, the International Society for Biological and Environmental Repositories, as well as ESBB, the European, Middle Eastern & African Society for Biopreservation & Biobanking.